Stay updated on Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2. No visible changes to study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-04-16T11:16:04.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 across the site.
    Difference
    0.0%
    Check dated 2026-03-18T19:27:20.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed on the page as part of the site version update.
    Difference
    0.0%
    Check dated 2026-03-11T17:11:43.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Core trial information appears unchanged; only minor visual or formatting differences are present in the page layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-18T04:41:58.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the lapse-in-government-funding notice and related operating-status updates were removed.
    Difference
    0.2%
    Check dated 2026-02-11T01:50:17.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    A government funding notice was added and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T01:28:53.000Z thumbnail image

Stay in the know with updates to Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.